Talecris Biotherapeutics discovers, develops, and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas, including immunology, pulmonology, and hemostasis.
Established in the United States on April 1, 2005, Talecris initially acquired the contributed assets of the worldwide plasma business of Bayer Biological Products and the contract manufacturing services of Precision Pharma Services in Melville, New York. In 2006, Talecris expanded into Canada and Europe, launched the Talecris Plasma Resources business, and acquired 58 plasma collection centers located throughout the US.
Talecris provides significant support to patient organizations and advocacy groups in the US and has been recognized for its corporate leadership, its manufacturing facilities, and its community efforts.
Consider a Talecris Career for personal satisfaction and professional growth.
View US distributor locations and contact information.
